SMID Cap Healthcare Convertibles : Conference Insights

The principals of Hillside Advisors have long been fans of biotech convertibles—it’s a match almost as good as what Mr. Reese came up with mixing chocolate and peanut butter.  Unlike most industries, biotech recognizes its need for a constant flow of capital-market lifeblood and acts accordingly. Biotech companies don’t hesitate to float new shares after good news catapults the stock.

Read More